The phrase "assay concentration" is correct and usable in written English.
It is typically used in scientific contexts, particularly in chemistry and biology, to refer to the measurement of the concentration of a substance in a sample.
Example: "The assay concentration of the drug was determined to be 50 mg/mL, indicating a strong presence in the solution."
Alternatives: "test concentration" or "measurement concentration".
Calculate the analytes -catechin and -epicatechin in the original sample as follows: Analyte in sample [µg/g] = assay concentration of analyte [µg/mL] * × [mL]/W sample [g].
Linearity of the method was tested from 10%too 300% of the targeted level of the assay concentration (diacerein 25 μg/mL, aceclofenac 50 μg/mL) for both analytes.
An aliquot of the extract (final assay concentration of tested samples corresponded to the extracts obtained from 0.01, 0.03, 0.1 and 3 g dry weight of C. aquatica per mL) was evaporated to dryness and biological activity of the extracts was determined by a cress bioassay as described latter.
An aliquot of the extract (final assay concentration of tested samples corresponded to the extracts obtained from 0.3, 1, 3, 10, 30, 100 and 300 mg dry weight of B. brizantha shoots per mL) was evaporated to dryness, dissolved in a 0.2 mL of methanol and added to a sheet of filter paper (No. 2) in a 3-cm Petri dish.
The stock of Rhabdastrellic acid-A was diluted, added to the wells for the desired final assay concentration.
When exceeding an assay concentration of 1 µM, hematin caused a graded decrease of the melt-peak heights for both interrogated SNP alleles.
The final assay concentrations of the enzyme and substrate were 0.75 nM and 50 nM, respectively.
Final assay concentrations were 75 nM radioligand and 0.25 mg/mL PPARγ-LBD-coated beads.
Analyte assay concentrations were compared.
All compounds were completely soluble at the final assay concentrations except as noted.
As assessed with the MTT assay, concentrations from 50 μM to 100 μM affected cell viability).
